### [2021-04-7](/feed/2021/04/7/index.md)

##### COVID-19 pandemic
# The Ministry of Health temporarily restricts the use of the Oxford–AstraZeneca vaccine to people over 60 years old following a report of a "possible link" with very rare blood clotting. 

BARCELONA, Spain (AP) — Spain joined other European nations on Wednesday in limiting the use of the AstraZeneca vaccine to the elderly due to concerns over links to extremely rare blood clotting.... 


### Sources:

1. [AP](https://apnews.com/article/europe-spain-coronavirus-pandemic-coronavirus-vaccine-760e317fab776973fd926aca5daec422) [Image](https://storage.googleapis.com/afs-prod/media/5e6534293b3c462cbc7dae68aa204a27/3000.jpeg)

### Changes:

1. Estonia suspends the use of the Oxford–AstraZeneca vaccine to people over 60 years old following report of possible link with the blood clotting cases.  _2021-04-08 01:05:50 (First version)_
2. Estonia suspends the use of the Oxford–AstraZeneca vaccine in people under 60 years old following a report of a possible link with cases of blood clotting.  _2021-04-08 03:05:58 (Update)_
3. Belgium temporarily restricts the use of the Oxford–AstraZeneca vaccine to people over 55 years old following a report from the European Medicines Agency that there is a "possible link" between the vaccine and very rare blood clotting cases.  _2021-04-08 03:06:03 (Update)_
3. The Ministry of Health temporarily restricts the use of the Oxford–AstraZeneca vaccine to people over 60 years old following a report of a "possible link" with very rare blood clotting.  _(Current version)_

### Related:

1. [Estonia suspends the use of the Oxford–AstraZeneca vaccine in people under 60 years old following a report of a possible link with cases of blood clotting. ](/feed/2021/04/7/estonia-suspends-the-use-of-the-oxford-astrazeneca-vaccine-in-people-under-60-years-old-following-a-report-of-a-possible.md) _Context: COVID-19 pandemic, Oxford–AstraZeneca, blood clot, vaccine_
2. [Belgium temporarily restricts the use of the Oxford–AstraZeneca vaccine to people over 55 years old following a report from the European Medicines Agency that there is a "possible link" between the vaccine and very rare blood clotting cases. ](/feed/2021/04/7/belgium-temporarily-restricts-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-55-years-old-following-a-report-f.md) _Context: COVID-19 pandemic, Oxford–AstraZeneca, blood clot, vaccine_
3. [German health authorities suspend the use of the Oxford–AstraZeneca vaccine in people under the age of 60 after new data showing a rise in unusual blood clots in the head was released. ](/feed/2021/03/30/german-health-authorities-suspend-the-use-of-the-oxford-astrazeneca-vaccine-in-people-under-the-age-of-60-after-new-data.md) _Context: COVID-19 pandemic, Oxford–AstraZeneca, blood clot, vaccine_
4. [The Public Health Agency of Sweden temporarily suspends the use of the Oxford-AstraZeneca vaccine pending a review from the European Medicines Agency following reports on abnormal blood clotting in vaccinated people. ](/feed/2021/03/16/the-public-health-agency-of-sweden-temporarily-suspends-the-use-of-the-oxford-astrazeneca-vaccine-pending-a-review-from.md) _Context: COVID-19 pandemic, Oxford–AstraZeneca, blood clot, vaccine_
5. [The Government of Ireland temporarily suspends the use of the Oxford–AstraZeneca vaccine following reports from the Norwegian Medicines Agency regarding serious blood clots developing in four people who received the vaccine, one of whom later died. ](/feed/2021/03/14/the-government-of-ireland-temporarily-suspends-the-use-of-the-oxford-astrazeneca-vaccine-following-reports-from-the-norw.md) _Context: COVID-19 pandemic, Oxford–AstraZeneca, blood clot, vaccine_
6. [The Danish Health Authority temporarily suspends the use of the Oxford-AstraZeneca vaccine for two weeks as a "precaution" following reports that some vaccinated people had experienced blood clots, causing one person to die after receiving the vaccine. It has not been determined whether there is a link between the vaccine and the clots. Norway and Iceland have also suspended their use of the vaccine. ](/feed/2021/03/11/the-danish-health-authority-temporarily-suspends-the-use-of-the-oxford-astrazeneca-vaccine-for-two-weeks-as-a-precautio.md) _Context: COVID-19 pandemic, Oxford–AstraZeneca, blood clot, vaccine_
7. [The Korea Disease Control and Prevention Agency extends the use of the Oxford-AstraZeneca vaccine to people aged 65 and older as overseas trials show its effectiveness. ](/feed/2021/03/11/the-korea-disease-control-and-prevention-agency-extends-the-use-of-the-oxford-astrazeneca-vaccine-to-people-aged-65-and.md) _Context: COVID-19 pandemic, Oxford–AstraZeneca, vaccine_
8. [South Africa suspends its rollout of the Oxford-AstraZenenca vaccine after research finds that the vaccine is less effective against the 501.V2 variant discovered in the country. ](/feed/2021/02/7/south-africa-suspends-its-rollout-of-the-oxford-astrazenenca-vaccine-after-research-finds-that-the-vaccine-is-less-effec.md) _Context: COVID-19 pandemic, Oxford–AstraZeneca, vaccine_
9. [Spain approves the use of the Oxford-AstraZeneca vaccine in people aged 18 to 55. ](/feed/2021/02/5/spain-approves-the-use-of-the-oxford-astrazeneca-vaccine-in-people-aged-18-to-55.md) _Context: COVID-19 pandemic, Oxford–AstraZeneca, vaccine_
10. [The Health Ministry announces that Spain will receive 20 million vaccine doses from Pfizer and BioNTech by early 2021. ](/feed/2020/11/10/the-health-ministry-announces-that-spain-will-receive-20-million-vaccine-doses-from-pfizer-and-biontech-by-early-2021.md) _Context: COVID-19 pandemic, Ministry of Health, vaccine_